CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Medical Coverage Policy Diagnosis and Treatment of Sacroiliac Joint Pain

Defines medical necessity criteria, coverage stance, prior authorization and coding for diagnostic intra-articular SIJ injections, therapeutic corticosteroid injections, minimally invasive sacroiliac joint (SIJ) fusion, and exclusion of radiofrequency denervation for BlueCHiP for Medicare and Commercial products.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyMedical Coverage Policy Diagnosis and Treatment of Sacroiliac Joint Pain

Policy CodePolicy N/A

Change TypeClarified

Effective DateNov 1, 2019

Next Review Date

Key ActionPrior authorization is required for BlueCHiP for Medicare and recommended for Commercial Products before MIS SIJ fusion; document six months of intensive non-operative treatment, exam findings, imaging, and >=75% pain reduction on separate diagnostic intra-articular anesthetic injections.

SourceLink

POLICY UPDATE CHANGES

Policy specifies MIS SIJ fusion medical necessity criteria including imaging, physical exam findings, conservative therapy duration, and >=75% pain reduction after diagnostic injections.

3Primary covered interventions (diagnostic injection, corticosteroid injection, MIS fusion)

1Interventions considered not covered (RFA)

75%Diagnostic pain reduction threshold

Coverage Summary

This policy addresses the diagnosis and treatment of sacroiliac joint (SIJ) pain, defining medical necessity criteria and coverage stance for diagnostic image-guided intra‑articular anesthetic injections, therapeutic corticosteroid injections, minimally invasive sacroiliac joint (MIS) fusion, and radiofrequency denervation (RFA). MIS SIJ fusion is described as medically necessary when specified clinical, physical exam, imaging, conservative therapy, and diagnostic injection response criteria are met; diagnostic and therapeutic intra‑articular injections are covered; RFA is excluded as not covered or not medically necessary due to insufficient evidence.

Quick facts and policy thresholds

Diagnostic injection pain reduction threshold>= 75% reduction of pain for the expected duration of the anesthetic on separate visits (each with different duration of action)

Conservative treatment duration requirement>= 6 months of intensive non-operative treatment (medication optimization, activity modification, bracing, active therapeutic exercise including home program)

Coverage stanceMixed — some interventions covered (diagnostic anesthetic injection, corticosteroid injection, MIS SIJ fusion when criteria met); RFA not covered / not medically necessary due to insufficient evidence

Primary covered interventions (count)3 — diagnostic anesthetic injection, corticosteroid (therapeutic) injection, minimally-invasive SIJ fusion

Interventions considered not covered (count)1 — radiofrequency denervation/ablation (RFA)

Medically Necessary Criteria

Medically necessary: Minimally-invasive surgical (MIS) fusion of the sacroiliac (SI) joint

MIS fusion is considered medically necessary when ALL of the following criteria are met:

ALL of the following

Clinical and treatment history: Have moderate to severe pain with functional impairment that persists despite a minimum six months of intensive non-operative treatment that must include medication optimization, activity modification, bracing, and active therapeutic exercise targeted at the lumbar spine, pelvis, SIJ and hip including home exercise program
Physical examination: A thorough physical examination demonstrating localized tenderness with palpation over the sacral sulcus (Fortin's point; i.e. at the insertion of the dorsal ligament inferior to the posterior superior iliac spine or PSIS) in the absence of tenderness of similar severity elsewhere (eg, greater trochanter; lumbar spine, coccyx) and that other obvious sources for their pain do not exist
Pain description: Patient's report of typically unilateral pain that is caudal to the lumbar spine (L5 vertebra), localized over the posterior SIJ, and consistent with SIJ pain
Provocative tests: Positive response to a cluster of 3 provocative tests (eg, Gaenslen's test; distraction test; Patrick's sign; posterior provocation test)
Imaging studies
- SI joint imaging: Imaging (plain radiographs and a CT or MRI) of the SI joint that excludes the presence of destructive lesions (tumor; infection), fracture, traumatic SIJ instability, or inflammatory arthropathy that would not be properly addressed by percutaneous SIJ fusion
- Lumbar imaging: Imaging of the lumbar spine (CT or MRI) to rule out neural compression or other degenerative condition that can be causing low back or buttock pain
- Pelvis imaging: Imaging of the pelvis (AP plain radiograph) to rule out concomitant hip pathology
Diagnostic injection response: At least 75 percent reduction of pain for the expected duration of the anesthetic(s) on separate visits (each with different duration of action), and the ability to perform previously painful maneuvers, following an image-guided, contrast-enhanced intra-articular SIJ injection>= 75% pain reduction
Exclusions: Absence of generalized pain behavior (eg, somatoform disorder) or generalized disorders (eg, fibromyalgia) that would confound diagnosis/treatment

Therapeutic injections prior requirement

Additional requirement for BlueCHiP for Medicare and Commercial Products:

Therapeutic injection trial: Trial of at least one therapeutic intra-articular SIJ injection (ie: corticosteroid injection) prior to MIS fusion

Coding

Medically necessary / covered CPTCPTCovered

27279	Arthrodesis, sacroiliac joint; percutaneous or minimally invasive (indirect visualization), with image guidance, includes obtaining bone when performed, and placement of trans device graft fixing
27096	Injection procedure for sacroiliac joint, anesthetic/steroid, with image guidance (fluoroscopy or CT) including arthrography when performed
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent; with or without arthrography

Radiofrequency ablation codingCPT

Unlisted

There is no specific CPT code for radiofrequency ablation of the sacroiliac joint; appropriate unlisted code should be used

Provider Actions

Prior Authorization

Prior authorization required

Prior authorization is required for BlueCHiP for Medicare and recommended for Commercial Products before minimally invasive sacroiliac (MIS) fusion. Affected procedure: MIS sacroiliac joint fusion.

Minimally invasive sacroiliac (SI) joint fusion (e.g., CPT 27279)

Documentation Required

Documentation requirements

Document at least six months of intensive non-operative treatment, results of provocative physical exam tests, diagnostic imaging studies, and documented >=75% pain reduction on separate image-guided, contrast-enhanced intra-articular SIJ anesthetic injections (each on separate visits with different anesthetic duration).

SI joint imaging: plain radiographs plus CT or MRI to exclude destructive lesions, fracture, instability, or inflammatory arthropathy
Lumbar spine imaging: CT or MRI to rule out neural compression or other degenerative causes
Pelvis imaging: AP plain radiograph to rule out hip pathology
Diagnostic injections: image-guided, contrast-enhanced intra-articular SIJ anesthetic injections on separate visits demonstrating >=75% pain reduction for the expected duration of the anesthetic(s)

Note

Coverage of injections and RFA

Diagnostic anesthetic and corticosteroid intra-articular sacroiliac joint injections are covered per the policy; radiofrequency ablation (RFA) of the SIJ is considered not covered for BlueCHiP for Medicare and not medically necessary for Commercial Products due to insufficient evidence.

Background and Evidence

Diagnosing SIJ pain is challenging because there is no single criterion standard and SIJ dysfunction often lacks consistent radiographic or laboratory abnormalities; multiple nearby structures (eg, lumbar facet joints, discs) can refer pain to the SIJ region, confounding history and physical exam. Because of this uncertainty, image‑guided intra‑articular anesthetic (contrast‑enhanced) injections using fluoroscopy or CT have been used diagnostically, with relief of pain after anesthetic suggesting an SIJ source. Treatments evaluated in the evidence base include corticosteroid intra‑articular injections, various radiofrequency ablation techniques, stabilization/fixation procedures, and minimally invasive SIJ fusion (with multiple RCTs and prospective studies supporting MIS fusion outcomes).

Topic	Summary
Diagnostic injection efficacy threshold	Requires >=75% reduction of pain for the expected duration of the anesthetic on separate visits (each with different duration of action) after an image-guided, contrast-enhanced intra-articular SIJ injection
RFA evidence	Insufficient — evidence includes small, mixed RCTs; some short-term benefit reported for cooled probe but overall evidence is insufficient to determine effect on health outcomes
MIS fusion evidence	Multiple randomized controlled trials and prospective studies cited showing positive outcomes for minimally invasive SIJ fusion versus non-surgical management

Fortin's point: localized tenderness at the sacral sulcus at the insertion of the dorsal ligament inferior to the posterior superior iliac spine (PSIS).

MIS fusion (minimally‑invasive surgical fusion or fixation of the sacroiliac joint): percutaneous or minimally invasive approaches to fixate or arthrodese the SIJ (eg, trans‑iliac implants such as triangular or threaded devices intended to promote fusion or fixation).

Name	Number	Type	Effective Date
Minimally-invasive Surgical (MIS) Fusion of the Sacroiliac (SI) Joint	L36406	LCD